I would agree with Chris's comments on the Netherlands and also the U.K. I think what's really interesting with the U.K. right now is that they've set up four e-health centres. Those e-health centres are actually taking clinical trials and linking them to population-based data so they can look at these longer-term outcomes. The comment about the statins was fascinating. They showed that the benefit of the statins, if you start earlier, increases with time, whereas if you start at 70 or 75, forget it; you're throwing good money after bad.
These are the kinds of things that are just fantastic. I can see more and more intelligent population-based models for actually getting the best value for your money coming from that environment.